![Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Journal of Thoracic Oncology Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4e5f3e38-1e4c-4569-b5ff-a5ca56f80010/gr2_lrg.jpg)
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Journal of Thoracic Oncology
![Insights into the Structure and Transport of the Lithium, Sodium, Magnesium, and Zinc Bis(trifluoromethansulfonyl)imide Salts in Ionic Liquids | The Journal of Physical Chemistry C Insights into the Structure and Transport of the Lithium, Sodium, Magnesium, and Zinc Bis(trifluoromethansulfonyl)imide Salts in Ionic Liquids | The Journal of Physical Chemistry C](https://pubs.acs.org/cms/10.1021/acs.jpcc.8b05573/asset/images/medium/jp-2018-05573j_0003.gif)
Insights into the Structure and Transport of the Lithium, Sodium, Magnesium, and Zinc Bis(trifluoromethansulfonyl)imide Salts in Ionic Liquids | The Journal of Physical Chemistry C
![Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Journal of Thoracic Oncology Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/097899fa-45ce-49a6-884e-c617ce65f60c/gr1_lrg.jpg)
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial - Journal of Thoracic Oncology
![Interferons, interferon‐like cytokines, and their receptors - Pestka - 2004 - Immunological Reviews - Wiley Online Library Interferons, interferon‐like cytokines, and their receptors - Pestka - 2004 - Immunological Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc7fa4fb-9d5f-4ef7-a943-39e79897815b/imr.v309.1.cover.jpg?trick=1659184273962)
Interferons, interferon‐like cytokines, and their receptors - Pestka - 2004 - Immunological Reviews - Wiley Online Library
![Characterization of semipurified enterocins produced by Enterococcus faecium strains isolated from raw camel milk - Journal of Dairy Science Characterization of semipurified enterocins produced by Enterococcus faecium strains isolated from raw camel milk - Journal of Dairy Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/996f9442-9194-4806-af7a-05cb3e4bc44e/gr1.jpg)
Characterization of semipurified enterocins produced by Enterococcus faecium strains isolated from raw camel milk - Journal of Dairy Science
![Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis - ESMO Open Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4b4ed50c-6960-48c7-94c4-3b77eb2f22c5/gr3ab.jpg)
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis - ESMO Open
![Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis - ESMO Open Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a9d309e1-79af-42b2-88de-373e4606d2cb/gr1a_lrg.jpg)